HIND
Vyome Holdings, Inc
Key Financials
Operating Income
$-10452570
↓ 35.3%
Gross Profit
$218771
↓ 95.7%
Net Income
$-10262007
↓ 43.9%
Revenue
$319714
↑ 24.4%
Total Assets
$6.5M
↑ 35.6%
Shareholders' Equity
$-253000.00
↓ 103.8%
EPS (Diluted)
$-4.86
↑ 64.9%
Total Liabilities
$2.7M
↓ 45.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HIND |
| Company Name | Vyome Holdings, Inc |
| CIK | 1427570 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 949-429-6680 |